Retatrutide 30 mg pen ZPHC (AQ pen)

Retatrutide 30 mg pen ZPHC

Retatrutide is an experimental medication designed to treat obesity and metabolic disorders.

Mechanism of action: It acts on multiple hormonal receptors, specifically GLP-1, GIP, and glucagon receptors, making it a “triple agonist.”

In clinical trials, it demonstrated significant weight loss: for example, in some participants, >20% in 48 weeks.